Business Context and Reporting Period
Company: NeuroOne Medical Technologies Corp (NMTC)
Filing Type: Form 8-K (Current Report)
Date of Report: January 8, 2025
Reporting Period: Event-based report regarding Nasdaq listing compliance status.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The report focuses exclusively on regulatory compliance regarding stock listing standards.
Material Changes
- Delisting Notice: On January 8, 2025, the Company received a letter from the Nasdaq Staff confirming continued non-compliance with the Minimum Bid Price Requirement (Rule 5550(a)(2)).
- Trigger Event: The closing bid price for common stock remained below $1.00 per share for 30 consecutive trading days, a condition first notified on July 11, 2024.
- Compliance Period Expiry: The 180-day compliance period granted by Nasdaq expired on January 7, 2025.
- Current Status: The Company's common stock is scheduled for delisting unless an appeal is filed. The Company intends to request a hearing before the Nasdaq Hearings Panel, which will stay delisting actions pending the hearing's outcome.
Guidance, Outlook, and Risks
- Management Action: The Company plans to timely request a hearing to appeal the delisting determination and present a plan to regain compliance.
- Trading Status: The stock will remain listed and eligible for trading on Nasdaq at least until the conclusion of the hearing process.
- Risk Disclosure: The filing explicitly states there can be no assurance that the Company will ultimately regain compliance or remain listed on Nasdaq.
Investor Verification Checklist
- Verify the current trading status of NMTC on Nasdaq following the appeal filing.
- Monitor the outcome of the hearing before the Nasdaq Hearings Panel.
- Review the specific plan the Company intends to present to regain the $1.00 minimum bid price.
- Check for subsequent filings regarding the final decision on the delisting determination.